Pages that link to "Q27010154"
Jump to navigation
Jump to search
The following pages link to The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics (Q27010154):
Displaying 50 items.
- Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy (Q26740207) (← links)
- Precision medicine for cancer with next-generation functional diagnostics (Q26780232) (← links)
- Exploitation of the Apoptosis-Primed State of MYCN-Amplified Neuroblastoma to Develop a Potent and Specific Targeted Therapy Combination (Q28118450) (← links)
- Inhibition of MARCH5 ubiquitin ligase abrogates MCL1-dependent resistance to BH3 mimetics via NOXA (Q28830560) (← links)
- Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma. (Q33634679) (← links)
- Farnesoid X receptor, a novel proto-oncogene in non-small cell lung cancer, promotes tumor growth via directly transactivating CCND1. (Q33674312) (← links)
- Gold Nanoparticles for BCR-ABL1 Gene Silencing: Improving Tyrosine Kinase Inhibitor Efficacy in Chronic Myeloid Leukemia (Q33701925) (← links)
- A synthetic-lethality RNAi screen reveals an ERK-mTOR co-targeting pro-apoptotic switch in PIK3CA+ oral cancers (Q35925179) (← links)
- The Mutant KRAS Gene Up-regulates BCL-XL Protein via STAT3 to Confer Apoptosis Resistance That Is Reversed by BIM Protein Induction and BCL-XL Antagonism (Q36092931) (← links)
- Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening (Q36192485) (← links)
- Comparative transcriptomics of elasmobranchs and teleosts highlight important processes in adaptive immunity and regional endothermy (Q36263368) (← links)
- A Hippo and Fibroblast Growth Factor Receptor Autocrine Pathway in Cholangiocarcinoma (Q36778814) (← links)
- Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition (Q36989342) (← links)
- Naoxintong/PPARα Signaling Inhibits H9c2 Cell Apoptosis and Autophagy in Response to Oxidative Stress. (Q37271200) (← links)
- Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cells (Q37416797) (← links)
- Interactome of E. piscicida and grouper liver proteins reveals strategies of bacterial infection and host immune response (Q37550238) (← links)
- FBW7 mutations mediate resistance of colorectal cancer to targeted therapies by blocking Mcl-1 degradation. (Q37580764) (← links)
- Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer (Q37690890) (← links)
- Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer. (Q38563530) (← links)
- miRNAs and ovarian cancer: a miRiad of mechanisms to induce cisplatin drug resistance (Q38633144) (← links)
- Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia. (Q38722012) (← links)
- Virtual screening, SAR, and discovery of 5-(indole-3-yl)-2-[(2-nitrophenyl)amino] [1,3,4]-oxadiazole as a novel Bcl-2 inhibitor (Q38722346) (← links)
- (±)-Gossypol induces apoptosis and autophagy in head and neck carcinoma cell lines and inhibits the growth of transplanted salivary gland cancer cells in BALB/c mice (Q38743654) (← links)
- KIF26B, a novel oncogene, promotes proliferation and metastasis by activating the VEGF pathway in gastric cancer (Q38743870) (← links)
- Inhibition of Bcl-2 family members sensitizes mesenchymal chondrosarcoma to conventional chemotherapy: report on a novel mesenchymal chondrosarcoma cell line (Q38746885) (← links)
- Pleurotus nebrodensis polysaccharide(PN50G) evokes A549 cell apoptosis by the ROS/AMPK/PI3K/AKT/mTOR pathway to suppress tumor growth (Q38790829) (← links)
- miR-30a-5p enhances paclitaxel sensitivity in non-small cell lung cancer through targeting BCL-2 expression (Q38795063) (← links)
- Prolyl isomerase Pin1 promotes survival in EGFR-mutant lung adenocarcinoma cells with an epithelial-mesenchymal transition phenotype (Q38804845) (← links)
- Heat-shock protein 27 (HSP27, HSPB1) is synthetic lethal to cells with oncogenic activation of MET, EGFR and BRAF. (Q38969858) (← links)
- The influential role of BCL2 family members in synovial sarcomagenesis. (Q40066050) (← links)
- Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression. (Q40343596) (← links)
- The Critical Role of Rab31 in Cell Proliferation and Apoptosis in Cancer Progression (Q40657337) (← links)
- Re-activation of mitochondrial apoptosis inhibits T-cell lymphoma survival and treatment resistance (Q40812418) (← links)
- Mitochondrial matrix chaperone and c-myc inhibition causes enhanced lethality in glioblastoma. (Q41043950) (← links)
- BH3-mimetics and BET-inhibitors elicit enhanced lethality in malignant glioma. (Q41879630) (← links)
- RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment (Q42079499) (← links)
- BCL-W has a fundamental role in B cell survival and lymphomagenesis (Q42177793) (← links)
- PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation (Q42283077) (← links)
- Surface marker profiling of SH-SY5Y cells enables small molecule screens identifying BMP4 as a modulator of neuroblastoma differentiation (Q42670722) (← links)
- Targeting apoptosis in acute myeloid leukaemia (Q44489428) (← links)
- Epithelial-to-mesenchymal transition antagonizes response to targeted therapies in lung cancer by suppressing BIM. (Q45070526) (← links)
- Mechanisms of Drug Resistance in Cancer: The Role of Extracellular Vesicles (Q46088676) (← links)
- Caspase cleavage of Mcl-1 impairs its anti-apoptotic activity and proteasomal degradation in non-small lung cancer cells (Q47277994) (← links)
- Transcriptomic analysis of gingival mesenchymal stem cells cultured on 3D bioprinted scaffold: A promising strategy for neuroregeneration (Q47298428) (← links)
- Synthetic Lethality of Combined Bcl-2 Inhibition and p53 Activation in AML: Mechanisms and Superior Antileukemic Efficacy (Q47302512) (← links)
- miR-509-3p promotes cisplatin-induced apoptosis in ovarian cancer cells through the regulation of anti-apoptotic genes (Q47367402) (← links)
- Inhibitors of apoptosis: clinical implications in cancer. (Q47607136) (← links)
- Direct Activation of BAX by BTSA1 Overcomes Apoptosis Resistance in Acute Myeloid Leukemia. (Q47670493) (← links)
- A constitutive BCL2 down-regulation aggravates the phenotype of PKD1-mutant-induced polycystic kidney disease. (Q47707521) (← links)
- Downregulation of MCL-1 and upregulation of PUMA using mTOR inhibitors enhance antitumor efficacy of BH3 mimetics in triple-negative breast cancer. (Q48158175) (← links)